Vertex Pharmaceuticals Inc / Ma

Kingsview Wealth Management, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

574

Value ($000)

260

Weight

0.0%

2020 Q3 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	260	0.0%	574	12/31/2025
2025 Q3	11/12/2025	220	0.0%	561	9/30/2025
2025 Q2	8/8/2025	222	0.0%	499	6/30/2025
2025 Q1	5/2/2025	264	0.0%	545	3/31/2025
2024 Q3	11/12/2024	208	0.0%	447	9/30/2024
2022 Q4	2/13/2023	397	0.0%	1,376	12/31/2022
2022 Q2	8/16/2022	704	0.0%	2,499	6/30/2022
2022 Q1	2/8/2024	688	0.0%	2,638	3/31/2022
2021 Q4	2/17/2022	601	0.0%	2,737	12/31/2021
2021 Q3	12/3/2021	522	0.0%	2,877	9/30/2021
2021 Q2	8/17/2021	589	0.0%	2,912	6/30/2021
2021 Q1	5/24/2021	604	0.0%	2,834	3/31/2021
2020 Q4	2/16/2021	878	0.1%	3,715	12/31/2020
2020 Q3	11/19/2020	662	0.1%	2,434	9/30/2020